Consumers to have more say on medicine access issues

7 September 2021 - Consumer involvement in Australia’s medicines choices has been further strengthened under a new strategic agreement Medicines ...

Read more →

Patient advocacy organisations and FDA drug approval: lessons from Aduhelm

23 July 2021 - In the wake of last month’s controversial FDA approval of Biogen’s Aduhelm, Alzheimer’s Association CEO Harry ...

Read more →

NICE feedback?

13 July 2021 - NICE is quite far along a NICE led process to review its methods and processes for ...

Read more →

CMS opens national coverage determination analysis on treatment for Alzheimer’s disease

12 July 2021 - Today, the Centers for Medicare & Medicaid Services is opening a National Coverage Determination analysis, a ...

Read more →

PHARMAC is seeking views on declining funding applications

29 June 2021 - PHARMAC is considering declining 97 inactive medicine funding applications.  ...

Read more →

Moving patient stories highlight opportunities to strengthen our health care systems for all Australians

24 June 2021 - It was an emotional evening among the nearly 200 in-person and online attendees at Parliament House last ...

Read more →

Efficient funding of chemotherapy review - submissions on discussion paper

18 June 2021 - The efficient funding of chemotherapy review discussion paper was released on 21 May 2021 to gain ...

Read more →

MSAC consultation process - changes to take effect from 1 July 2021

16 June 2021 - MSAC is implementing changes to its consultation process from 1 July 2021.  ...

Read more →

Repurposing of prescription medicines

4 February 2021 - The Therapeutic Goods Administration is conducting a public consultation that seeks to understand potential obstacles and ...

Read more →

The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies

18 January 2021 - Historically, Australia has been at the forefront of the application of HTA for assessing the effectiveness and ...

Read more →

Strengthening patient outcome evidence in health technology assessment: a coproduction approach

13 January 2021 - NICE worked with patients and staff from six patient organisations to review existing health technology assessment ...

Read more →

Stage 2 PBS process improvements – consultation closed

13 October 2020 - On 21 September 2020, the department hosted a webinar to provide information to industry on the ...

Read more →

Patients, users, caregivers, and citizens' involvement in local health technology assessment unit in Quebec: a survey

29 September 2020 - The aim of the survey was to provide an overview of local health technology assessment unit practices ...

Read more →

PHARMAC seeking views on widened access to juvenile idiopathic arthritis medicines

11 September 2020 - PHARMAC is looking at widening access to three funded treatments – adalimumab, etanercept and tocilizumab – to ...

Read more →

PHARMAC seeking views on new type 2 diabetes medicines

9 September 2020 - PHARMAC is looking at funding two new medicines with substantial health benefits for up to 50,000 ...

Read more →